21272 ⎘
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient; Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
Stabilized vancomycin formulations
#602Compositions for Delivering Drugs with Low Water Solubility
#603Saponin nano micelle, preparing method, application and pharmaceutical composition thereof
#604Sustained-release lipid pre-concentrate of GNRH analogues and pharmaceutical composition comprising the same
#605Core-shell nanoparticle including nucleic acid hydrogel and method of producing the same
#606Lipids and compositions for the delivery of therapeutics
#607SUSTAINED-RELEASE LIPID PRE-CONCENTRATE OF CATIONIC PHARMACOLOGICALLY ACTIVE SUBSTANCE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
#608Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using the same
#609Method for Separating Components in Natural Oil
#610Asymmetric ionizable cationic lipid for RNA delivery
#611Composition with increased bioavailability of orally administered embryo-peptides and process for its obtainment
#612Nanoparticle formulation
#613ORAL FILM FORMULATIONS COMPRISING DAPOXETINE AND TADALAFIL
#614Mesenchymal stem cell particles
#615PHARMACEUTICAL FORMULATIONS COMPRISING PARAOXONASE
#616Vesicles comprising epidermal growth factor and compositions thereof
#617Liposomes useful for drug delivery
#618Methods of treating arthritis
#619Pharmaceutical composition comprising 3-beta-hydroxy-5-alpha-pregnan-20-one with improved storage and solubility properties
#620Polymer-carbohydrate conjugates for drug delivery technology
#621Ophthalmic drug delivery system containing phospholipid and cholesterol
#622NON-IONIC VESICLE FORMULATIONS OF CALCIUM CHANNEL BLOCKERS
#623Heparosan-Multimolecular Assembly Drug Delivery Compositions and Methods of Making and Using Same
#624Compositions and methods for modulating hemoglobin gene family expression
#625NANOLIPOSOMAL CYCLOSORIN FORMULATIONS FOR IMMUNOSUPPRESION AND METHODS FOR THE PRODUCTION THEREOF
#626COMPOSITIONS CONTAINING KINASE INHIBITORS
#627Carbohydrate conjugates as delivery agents for oligonucleotides
#628Carbohydrate conjugates as delivery agents for oligonucleotides
#629AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#630Bolaamphiphilic compounds, compositions and uses thereof
#631ABSORPTION ENHANCERS SUCH AS E.G. BHT, BHA OR PROPYL GALLATE
#632Lipid-derived neutral nanoparticles
#633METHODS AND COMPOSITIONS FOR THERAPEUTIC AGENTS
#634SUSTAINED-RELEASE DRUG CARRIER COMPOSITION
#635Diether based biodegradable cationic lipids for siRNA delivery
#636Methods and related compositions for reduction of fat and skin tightening
#637Reverse micelle system comprising nucleic acids and use thereof
#638Sustained-release drug carrier composition
#639Reversibly crosslinked micelle systems
#640METHODS AND FORMULATIONS FOR CONVERTING INTRAVENOUS AND INJECTABLE DRUGS INTO ORAL DOSAGE FORMS
#641Lipid construct for delivery of insulin to a mammal
#642METHODS AND FORMULATIONS FOR ENHANCING THE ABSORPTION AND DECREASING THE ABSORPTION VARIABILITY OF ORALLY ADMINISTERED DRUGS, VITAMINS AND NUTRIENTS
#643Formulas for diagnosing and treating hormone-dependent cancers and cancers of the organs responsible for steroid hormone synthesis
#644Delivery and formulation of engineered nucleic acids
#645Tandem facial amphiphiles
#646Carbohydrate conjugates as delivery agents for oligonucleotides
#647Pharmaceutical compositions to reduce complications of ocular steroid
#648Method for delivering alpha-melanocyte stimulating hormone mimetibody composition comprising propylene glycol for intranasal administration to the central nervous system
#649USE OF AN ANTIBODY AND A PARTICULATE IMMUNOMODULATOR
#650COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS
#651Robotic guidance of ultrasound probe in endoscopic surgery
#652Sustained release of antiinfectives
#653Lipids, lipid compositions, and methods of using them
#654Liposomal cisplatin compositions for cancer therapy
#655LIPOSOME OXALIPLATIN COMPOSITIONS FOR CANCER THERAPY
#656Resorption enhancers as additives to improve the oral formulation of low molecular weight heparins
#657PREPARATION COMPRISING HEXOSE-6-PHOSPHATE-MODIFIED CHOLESTEROL DERIVATIVE
#658Orally bioavailable lipid-based constructs
#659INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN THE ISOELECTRIC POINT OF WHICH IS COMPRISED IN 5.8 AND 8.5 AND AN ANIONIC COMPOUND BEARING CARBOXYLATE CHARGES AND HYDROPHOBIC RADICALS
#660LIPOSOME PRODUCTION USING ISOPROPANOL
#661Mucosal delivery of drugs
#662Targeting lipids
#663Pharmaceutical/cosmetic compositions comprising hyaluronic acid and treatment of dermatological conditions therewith
#664Reduction of flake-like aggregation in nanoparticulate active agent compositions
#665Lyophilization of Virosomes
#666Controlled release mucoadhesive systems
#667Methods and related compositions for reduction of fat and skin tightening
#668pH sensitive carrier and preparation method thereof, and pH sensitive drug and pH sensitive drug composition each containing the carrier, and method for treating or preventing diseases using the same
#669PROCESS FOR PRODUCING AQUEOUS SOLUTION CONTAINING FAT-SOLUBLE SUBSTANCE
#670Lipid construct for delivery of insulin to a mammal
#671Carrier for negatively charged drugs comprising a cationic lipid and a preparation method thereof
#672Lipid delivery formulations
#673Zwitterionic lipids
#674Pharmaceutical Composition Suitable for Use in a Dry Powder Inhaler
#675Preparation for treatment of spinal cord injury
#676PHARMACEUTICAL/ COSMETIC COMPOSITION COMPRISING HYALURONIC ACID AND TREATMENT OF DERMATOLOGICAL CONDITIONS THEREWITH
#677Method for separating components in natural oil
#678Tandem facial amphiphiles
#679Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs
#680Pharmaceutical composition in which solubility of partially soluble tricyclic derivative is improved
#681Reverse micelle system comprising nucleic acids and use thereof
#682Cationic lipids and methods of use thereof
#683SKIN IRRITATION SUPPRESSANT AND TRANSDERMAL PREPARATION
#684Resorption enhancers as additives to improve the oral formulation of non-anticoagulant sulfated polysaccharides
#685MEDICINAL TARGETED LOCAL LIPOLYSIS
#686PHARMACEUTICAL COMPOSITION COMPRISING 3-BETA-HYDROXY-5-ALPHA-PREGNAN-20-ONE WITH IMPROVED STORAGE AND SOLUBILITY PROPERTIES
#687Phospholipid depot
#688SUBMICRO EMULSION OF PACLITAXEL USING STEROID COMPLEX AS INTERMEDIATE CARRIER
#689Composite Material and Method for Producing the Same
#690Engineered nucleic acids encoding a modified erythropoietin and their expression
#691HIGHLY MONODISPERSE BRANCHED PEG-LIPID CONJUGATES
#692COMPOSITION FOR PROMOTING WOUND HEALING
#693METHODS AND COMPOSITIONS FOR IMPROVED RIFAMYCIN THERAPIES
#694Liposomes useful for drug delivery
#695ORALLY ABSORBED PHARMACEUTICAL FORMULATION AND METHOD OF ADMINISTRATION
#696Carbohydrate conjugates as delivery agents for oligonucleotides
#697Carrier comprising a vitamin E derivative
#698Transmembrane penetration enhancer
#699PROCESS FOR PRODUCING LIPOSOMES BY TWO-STEP EMULSIFICATION METHOD UTILIZING OUTER AQUEOUS PHASE CONTAINING SPECIFIC DISPERSING AGENT, PROCESS FOR PRODUCING LIPOSOME DISPERSION OR DRY POWDER THEREOF USING THE PROCESS FOR PRODUCING LIPOSOMES, AND LIPOSOME DISPERSION OR DRY POWDER THEREOF PRODUCED THEREBY
#700NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS
#701Liposomal nanoparticles and other formulations of fenretinide for use in therapy and drug delivery
#702Pharmaceutical anti-infective composition for inhalation
#703Nanoparticle-based tumor-targeted drug delivery
#704Lipids and compositions for the delivery of therapeutics
#705COMPOSITIONS FOR SITE-SPECIFIC DELIVERY OF IMATINIB AND METHODS OF USE
#706Lipids and compositions for the delivery of therapeutics
#707Lipids and compositions for the delivery of therapeutics
#708NANOPARTICLE PHARMACEUTICAL FORMULATIONS
#709DELIVERY AGENTS FOR ENHANCING MUCOSAL ABSORPTION OF THERAPEUTIC AGENTS
#710Novel Lipid Nanoparticles and Novel Components for Delivery of Nucleic Acids
#711LIPIDS, LIPID COMPOSITIONS, AND METHODS OF USING THEM
#712Amino acid lipids and uses thereof
#713Lipid Construct for Delivery of Insulin to a Mammal
#714Intranasal administration of active agents to the central nervous system
#715Sustained-release drug carrier composition
#716METHODS AND FORMULATIONS FOR ENHANCING THE ABSORPTION AND DECREASING THE ABSORPTION VARIABILITY OF ORALLY ADMINISTERED DRUGS, VITAMINS AND NUTRIENTS
#717METHOD FOR PRODUCING MICROCAPSULES USING SOLID FAT
#718Ophthalmic drug delivery system containing phospholipid and cholesterol
#719Dried formulations of nanoparticle-coated capsules
#720MESENCHYMAL STEM CELL PARTICLES
#721METHODS AND RELATED COMPOSITIONS FOR REDUCTION OF FAT
#722Method for producing biologically ingestible material and biologically ingestible material obtained therefrom
#723REDUCTION OF FLAKE-LIKE AGGREGATION IN NANOPARTICULATE ACTIVE AGENT COMPOSITIONS
#724Orally bioavailable lipid-based constructs
#725Methods and Related Compositions for Reduction of Fat and Skin Tightening
#726Water-Containing Composition Which Can Be Used As External Composition
#727TRANSDERMALLY ABSORPTIVE PREPARATION
#728Sustained release of antiinfectives
#729Nanoparticles comprising a drug, ethylcellulose, and a bile salt
#730Lipid composition having excellent shape retention property and product
#731Pharmaceutical Anit-Infective Composition for Inhalation
#732DRIED FORMULATIONS
#733Pharmaceutical anti-infective composition for inhalation
#734Medicinal composition for transdermal absorption, medicinal composition storing unit and transdermal absorption preparation using the same
#735Water-soluble compositions of bioactive lipophilic compounds
#736Absorption enhancers such as E.G. BHT, BHA or propyl gallate
#737Medicinal targeted local lipolysis
#738Water-soluble compositions of bioactive lipophilic compounds
#739AQUEOUS SOLVENT SYSTEM FOR SOLUBILIZATION OF AZOLE COMPOUNDS
#740NANOPARTICULATE TACROLIMUS FORMULATIONS
#741Targeting Lipids
#742Carbohydrate conjugates as delivery agents for oligonucleotides
#743COMPOSITIONS FOR SITE-SPECIFIC DELIVERY OF IMATINIB AND METHODS OF USE
#744Water-based delivery systems
#745Orally Absorbed Pharmaceutical Formulation and Method of Administration
#746Intranasal Administration of Active Agents to the Central Nervous System
#747METHODS AND FORMULATIONS FOR CONVERTING INTRAVENOUS AND INJECTABLE DRUGS INTO ORAL DOSAGE FORMS
#748Water-based delivery systems
#749Methods and compositions for delivery of pharmaceutical agents
#750Phamaceutical/cosmetic compositions comprising hyaluronic acid and treatment of dermatological conditions therewith
#751Amino acid lipids and uses thereof
#752PHARMACEUTICAL COMPOSITIONS COMPRISING A POORLY WATER-SOLUBLE ACTIVE INGREDIENT, A SURFACTANT AND A WATER-SOLUBLE POLYMER
#753Lyophilization of virosomes
#754Camptothecin-analog with a novel, “flipped” lactone-stable, E-ring and methods for making and using same
#755TRANSFECTION AGENTS
#756Compositions for antigen-specific induction of tolerance
#757Dried Formulations of Nanoparticle-Coated Capsules
#758Use Of A Steroid For Enhancement Of Skin Permeability
#759Nanoparticulate tacrolimus formulations
#760METHODS AND FORMULATIONS FOR ENHANCING THE ABSORPTION AND DECREASING THE ABSORPTION VARIABILITY OF ORALLY ADMINISTERED DRUGS, VITAMINS AND NUTRIENTS
#761Formulations containing alkylphosphocholines using novel negative charge carriers
#762Water-soluble compositions of bioactive lipophilic compounds
#763Composition of a polypeptide and an amphiphilic compound in an ionic complex and the use thereof
#764Preparation of Aqueous Clear Solution Dosage Forms with Bile Acids
#765Pharmaceutical formulations comprising paraoxonase
#766Compositions and methods for non-parenteral delivery of oligonucleotides
#767Drug delivery means
#768Formulations for mediating inflammatory bowel disorders
#769COMPOSITION FOR INTESTINAL DELIVERY
#770Liposomes useful for drug delivery
#771Methods and compositions for oral administration of proteins
#772Absorption enhancers such as e.g. BHT, BHA or propyl gallate
#773Method of chemically stabilizing pharmaceutical formulations with cholesterol
#774Nanoparticulate tacrolimus formulations
#775Methods and related compositions for reduction of fat and skin tightening
#776Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs
#777Sustained release of antiinfectives
#778Tolerance of 4-(4-(2-pyrrolycarbonyl)-1-piperazinyl)-3-trifluoromethyl-benzoylguanidine in intravenous administration
#779Room temperature stable aqueous liquid pharmaceutical composition
#780Methods and related compositions for reduction of fat
#781Delivery agents for enhancing mucosal absorption of therapeutic agents
#782Pleasant-tasting aqueous liquid composition of prednisolone sodium phosphate
#783Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof
#784Water-based delivery systems
#785Composition of a polypeptide and an amphiphilic compound in an ionic complex and the use thereof
#786Medicinal targeted local lipolysis
#787Transfection agents
#788Synthesis and use of reagents for improved DNA lipofection and/or slow release prodrug and drug therapies
#789Aqueous 2,6-diisopropylphenol pharmaceutical compositions
#790Topical use of cytokines and chemokines for the treatment of viral or mykotic skin diseases or tumoral diseases
#791Manufacturing of bupivacaine multivesicular liposomes
#792Manufacturing of bupivacaine multivesicular liposomes
#793Tadalafil oral transmucosal film
#794Compositions and methods for treating epilepsy
#795Compositions and methods for treating epilepsy
#796Compositions and methods for treating epilepsy
#797Extract of as antifungal agent
#798Nanoformulation of spriooxindole and methods for treating hepatocellular carcinoma
#799Pharmaceutical compositions and methods for treating hypertension
#800Enhanced Rodeferin broad spectrum
#801Liposomal nanoparticle essential oil composition for nostril administration
#802Method for preparing liposomes containing an essential oil in an oil-in-water emulsion
#803Manufacturing of bupivacaine multivesicular liposomes
#804Hydroxytyrosol ursodeoxycholic acid ester with antioxidant activity and a method of preparing the same
#805Compositions and method for sustained drug delivery by active transdermal technology